secwatch / observer
8-K filed October 5, 2021, 7:59 PM ET ticker CRMD CIK 0001410098
leadership confidence high sentiment neutral materiality 0.60

CorMedix CEO and EVP retire; CFO Matthew David named interim CEO

CorMedix Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Matthew David

Interim Chief Executive Officer
CRMD · CorMedix Inc.
Effective
2021-10-04
Filed
October 5, 2021, 7:59 PM ET
Matthew David, M.D., the Company’s current Chief Financial Officer, will serve as interim Chief Executive Officer, effective immediately, until a new Chief Executive Officer is appointed.
Departed

John L. Armstrong, Jr.

Executive Vice President, Technical Operations
CRMD · CorMedix Inc.
Effective
2021-10-04
Filed
October 5, 2021, 7:59 PM ET
On October 4, 2021, the Company and John L. Armstrong, Jr. came to a mutual agreement pursuant to which Mr. Armstrong will retire from his position as the Company’s Executive Vice President, Technical Operations, effective October 4, 2021.
Departed (interim)

Khoso Baluch

Chief Executive Officer
CRMD · CorMedix Inc.
Effective
2021-10-04
Successor
Matthew David
Filed
October 5, 2021, 7:59 PM ET
On October 1, 2021, the Company and Khoso Baluch came to a mutual agreement pursuant to which Mr. Baluch will retire from his position as the Company’s Chief Executive Officer, effective October 4, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew David was appointed as Interim Chief Executive Officer at CorMedix Inc..

Action
appointed
Role
Interim Chief Executive Officer
Exact text from the filing
Matthew David, M.D., the Company’s current Chief Financial Officer, will serve as interim Chief Executive Officer, effective immediately, until a new Chief Executive Officer is appointed.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John L. Armstrong, Jr. retired as Executive Vice President, Technical Operations at CorMedix Inc..

Action
retired
Role
Executive Vice President, Technical Operations
Exact text from the filing
On October 4, 2021, the Company and John L. Armstrong, Jr. came to a mutual agreement pursuant to which Mr. Armstrong will retire from his position as the Company’s Executive Vice President, Technical Operations, effective October 4, 2021.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Khoso Baluch retired as Chief Executive Officer at CorMedix Inc..

Action
retired
Role
Chief Executive Officer
Exact text from the filing
On October 1, 2021, the Company and Khoso Baluch came to a mutual agreement pursuant to which Mr. Baluch will retire from his position as the Company’s Chief Executive Officer, effective October 4, 2021.
View on SEC.gov

CorMedix Inc. filing history →

Source: SEC EDGAR
accession 0001013762-21-000153
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.